BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C

  Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, has closed four new investments across four countries over the past few months

  February 22, 2019

   · 

  6 min read
• Business

  Discovery Park announces Chris Broom as Head of Business Development

  Discovery Park, a park playing a key role in the South East of England’s life sciences community, has announced the appointment of Chris Broom as Head of Business Development.

  February 22, 2019

   · 

  2 min read
• Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

  Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing co-led by Gilde Healthcare and Inkef Capital.

  February 22, 2019

   · 

  5 min read
• Drug Development

  AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006

  AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer’s disease and Progressive Supranuclear Palsy (PSP), announced today the successful completion of the latest phase 1 study regarding the effect of food intake for its drug candidate AZP2006.

  February 22, 2019

   · 

  3 min read
• Business

  Visioneering Launches NaturalVue® Brand Contact Lenses for Myopia Progression Control & Presbyopia in the United Kingdom

  US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘The Company’) has announced its launch into the UK.

  February 22, 2019

   · 

  1 min read
• Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

  The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt®, hosted by Innovent Biologics, Inc., and co-sponsored by the China Association of Productivity Promotion Centers, was successfully held in Beijing

  February 22, 2019

   · 

  5 min read
• Business

  Oncopeptides AB: Year-end Report 2018

  At the company’s Capital Markets Day in December, an updated strategy for Oncopeptides’ business was presented

  February 22, 2019

   · 

  3 min read
• Novostia Technology for Heart Valve Prosthesis Raises CHF 6.5 Million to Start First Clinical Trials

  Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.

  February 22, 2019

   · 

  1 min read
• Business

  Lays Pain Oil Spray Available on Amazon

  Marshalls Traditional Healthcare product helps people soothe pains naturally

  February 22, 2019

   · 

  1 min read
• Business

  Make 2019 Your Year of Health with Nupure Probiflor and Probipure Junior Probiotics -- Coming Soon to Amazon

  AixSwiss B.V.'s Nupure probiotics is perfect to help you make 2019 your year of health.

  February 22, 2019

   · 

  1 min read